The Indian Council for Medical Research (ICMR) tie-up with Bharat Biotech to develop indigenous COVID-19 vaccine. The vaccine is to be developed using virus strains that have been isolated from COVD-19 patients at ICMR’s National Institute of Virology (NIV), Pune.
ICMR has shared one of the 11 virus strains that it managed to culture with Bharat Biotech. The industry partnership is to develop the vaccine candidate and ICMR has transferred the technology to them One of the strains has now been successfully transferred from NIV to Bharat Biotech International Ltd. (BBIL) in Hyderabad as part of the partnership. ICMR-NIV will provide continuous support to BBIL for vaccine development.
Important takeaways for all competitive exams
Honorable Prime Minister Narendra Modi inaugurated the India's first Namo Bharat Rapid Rail Transit System…
India’s corporate sector is moving beyond traditional CSR and integrating sustainability into core business strategy.…
The AI Impact Summit 2026 concluded in New Delhi on 19 February 2026 with the…
The 2026 Winter Olympics, officially the XXV Olympic Winter Games, were held in Milan and…
Did you know that the colorful bell peppers you see in markets—red, yellow, and green—are…
The 79th British Academy Film Awards (BAFTA 2026), organized by the British Academy of Film…